Latest News
RBA lifts interest rates for third month in a row
Australia’s Reserve Bank increased its key cash interest rate for the third time in as many months and warned of more action as it looked to stymie rising inflation.
Biffa talks with ECP ongoing, takeover deadline extended
Waste management company Biffa said on Tuesday that the UK Takeover Panel has extended the deadline for private equity firm Energy Capital Partners to make a takeover offer as talks between the two parties are ongoing.
B&M names Mike Schmidt as CFO
Variety goods value retailer B&M European Value Retail named Mike Schmidt as its next chief financial officer on Tuesday, succeeding Alex Russo.
Asia report: Shares edge higher on US-China trade hopes; RBA lifts rates
Asian shares were broadly higher after the US Independence Day holiday as Australia’s central bank raised interest rates for the third consecutive month and investors took heart from a possible easing of China-US trade tensions.
Sainsbury's Q1 sales fall, AstraZeneca agrees to acquire TeneoTwo
London pre-open The FTSE 100 was being called to open 18. 5 points higher ahead of the bell on Tuesday after closing 0. 89% higher in the previous session at 7,232. 65.
London pre-open: Stocks set for positive start
London stocks were set to rise at the open on Tuesday following a mostly positive Asian session.
Tuesday newspaper round-up: Customer service complaints, floating windfarms, Halifax
Customer service complaints have hit their highest level on record and are costing British businesses more than £9bn a month in lost staff time, research has found. As firms struggle to cope with global supply issues and a staffing crisis, the Institute of Customer Service found more consumers were experiencing service issues than at any point since its customer satisfaction index began in 2008. – Guardian.
AstraZeneca agrees to acquire TeneoTwo
Drugmaker AstraZeneca has agreed to acquire TeneoTwo and its clinical-stage T-cell engager in a deal worth up to $1. 26bn as part of an effort to accelerate the development of the potential new medicine for B-cell haematologic malignancies.